SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pharmos (PARS)
An SI Board Since October 1998
Posts SubjectMarks Bans Symbol
1386 42 0 PARS
Emcee:  Dr. John M. de Castro Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
411 Ariella & Dr. De Castro- I agree that it would be nice to see some sort of Tony van Werkhooven-1/9/1999
410 Your point is well taken. I am concerned like you about the possibility that fAriella-1/9/1999
409 Ariella, What are the chances of talking PARS management into making a preliminDr. John M. de Castro-1/9/1999
408 Hi Rick - To the best of my knowledge, LE-T remains on schedule for NDA by midAriella-1/8/1999
407 Ariella, assuming that the LE-T Phase III trials are completed by late FebruaryRick Strange-1/8/1999
406 Arnie -- thanks so much for posting that info. ;-) Ariella (eom)Ariella-1/8/1999
405 Hi: The thread has gotten rather quiet as our favorite stock seems to be languiarnie h-1/8/1999
404 Hi Ariella, This may be off topic, but regarding your problems this could be iDinoRia-1/6/1999
403 I just spoke with PARS and am told that, at last, ALL extra toxicity tests on LAriella-1/6/1999
402 Zvi - similar thing going on in Britain. See Yahoo thread for link. (eom)Ariella-1/6/1999
401 Interesting....... MKs mull medical marijuana Zvi Steinberg-1/5/1999
400 We're not alone (said ironically) <<Biotech Investor Shares Dreams, FAriella-1/5/1999
399 Pharma waits for better guidelines before jumping on the Web signalsmag.com rAriella-1/5/1999
398 Very well done, Yosi. Hat's off for a superb, easy-reading, synopsis of ouRon-1/4/1999
397 REQUESTED LINKS, Hi Omer & Company, Does anyone have a link to the newer BRAVEHEART-1/4/1999
396 1. The P-3 study for HU 211 is anticipated for what specific indication? Phayosi s-1/4/1999
395 Hi Yosi, Thanks for your efforts. What you describe is optimistic based on theBRAVEHEART-1/4/1999
394 "...for relatives with conditions like Alzheimer's disease, Parkinsonyosi s-1/4/1999
393 Pars had a financing about a year ago with a convertible debenture. that is mosyosi s-1/4/1999
392 Hi yosi s, Could you describe to me what sort of conversion process is PARS unBRAVEHEART-1/3/1999
391 Neuroinvestor, It is very difficult to due 'all the due diligence and recrysball-1/3/1999
390 Hardly small-minded, NeuroInvestment... and duly noted <eom> cm-1/3/1999
389 While this may seem small-minded, I want to point out that the posting by PillXNeuroInvestment-1/3/1999
388 Zvi, Ariealla, et al, A very insightful and important post by Pillx. If HU2crysball-1/3/1999
387 Help Needed Had unfortunate problems with AOL software over the weekend that reAriella-1/3/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News